nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB1—stomach cancer	0.469	0.543	CbGaD
Phenylpropanolamine—ADRB2—stomach cancer	0.395	0.457	CbGaD
Phenylpropanolamine—Euphoric mood—Floxuridine—stomach cancer	0.00266	0.048	CcSEcCtD
Phenylpropanolamine—Drowsiness—Mitomycin—stomach cancer	0.00136	0.0245	CcSEcCtD
Phenylpropanolamine—Confusional state—Floxuridine—stomach cancer	0.00111	0.0201	CcSEcCtD
Phenylpropanolamine—Vision blurred—Mitomycin—stomach cancer	0.001	0.0181	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Floxuridine—stomach cancer	0.000909	0.0164	CcSEcCtD
Phenylpropanolamine—Confusional state—Mitomycin—stomach cancer	0.000873	0.0158	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Fluorouracil—stomach cancer	0.000867	0.0157	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Floxuridine—stomach cancer	0.000813	0.0147	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Mitomycin—stomach cancer	0.000772	0.014	CcSEcCtD
Phenylpropanolamine—Somnolence—Mitomycin—stomach cancer	0.00077	0.0139	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Docetaxel—stomach cancer	0.000729	0.0132	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Docetaxel—stomach cancer	0.000729	0.0132	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Capecitabine—stomach cancer	0.000718	0.013	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Mitomycin—stomach cancer	0.000713	0.0129	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Capecitabine—stomach cancer	0.000705	0.0127	CcSEcCtD
Phenylpropanolamine—Vomiting—Floxuridine—stomach cancer	0.000701	0.0127	CcSEcCtD
Phenylpropanolamine—Irritability—Fluorouracil—stomach cancer	0.000699	0.0126	CcSEcCtD
Phenylpropanolamine—Rash—Floxuridine—stomach cancer	0.000696	0.0126	CcSEcCtD
Phenylpropanolamine—Dermatitis—Floxuridine—stomach cancer	0.000695	0.0126	CcSEcCtD
Phenylpropanolamine—Ataxia—Fluorouracil—stomach cancer	0.000689	0.0125	CcSEcCtD
Phenylpropanolamine—Tranylcypromine—CYP2A6—stomach cancer	0.00067	0.215	CrCbGaD
Phenylpropanolamine—Nausea—Floxuridine—stomach cancer	0.000655	0.0118	CcSEcCtD
Phenylpropanolamine—Liver injury—Epirubicin—stomach cancer	0.000584	0.0106	CcSEcCtD
Phenylpropanolamine—Ephedrine—ADRB2—stomach cancer	0.000574	0.184	CrCbGaD
Phenylpropanolamine—Dizziness—Mitomycin—stomach cancer	0.000573	0.0103	CcSEcCtD
Phenylpropanolamine—Vomiting—Mitomycin—stomach cancer	0.00055	0.00995	CcSEcCtD
Phenylpropanolamine—Rash—Mitomycin—stomach cancer	0.000546	0.00987	CcSEcCtD
Phenylpropanolamine—Dermatitis—Mitomycin—stomach cancer	0.000545	0.00986	CcSEcCtD
Phenylpropanolamine—Liver injury—Doxorubicin—stomach cancer	0.00054	0.00977	CcSEcCtD
Phenylpropanolamine—Dyskinesia—Epirubicin—stomach cancer	0.000523	0.00945	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—ADRB1—stomach cancer	0.000517	0.166	CrCbGaD
Phenylpropanolamine—Nausea—Mitomycin—stomach cancer	0.000514	0.00929	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Epirubicin—stomach cancer	0.0005	0.00904	CcSEcCtD
Phenylpropanolamine—Ataxia—Docetaxel—stomach cancer	0.000497	0.00899	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Epirubicin—stomach cancer	0.000491	0.00888	CcSEcCtD
Phenylpropanolamine—Flushing—Irinotecan—stomach cancer	0.000491	0.00888	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—stomach cancer	0.000491	0.157	CrCbGaD
Phenylpropanolamine—Irritability—Capecitabine—stomach cancer	0.000489	0.00883	CcSEcCtD
Phenylpropanolamine—Urinary retention—Capecitabine—stomach cancer	0.000487	0.0088	CcSEcCtD
Phenylpropanolamine—Dyskinesia—Doxorubicin—stomach cancer	0.000484	0.00874	CcSEcCtD
Phenylpropanolamine—Ataxia—Capecitabine—stomach cancer	0.000481	0.0087	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Irinotecan—stomach cancer	0.000473	0.00855	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Doxorubicin—stomach cancer	0.000463	0.00837	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Doxorubicin—stomach cancer	0.000455	0.00822	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Fluorouracil—stomach cancer	0.000453	0.00818	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—ADRB2—stomach cancer	0.000435	0.139	CrCbGaD
Phenylpropanolamine—Amphetamine—CYP2A6—stomach cancer	0.000432	0.138	CrCbGaD
Phenylpropanolamine—Vision blurred—Fluorouracil—stomach cancer	0.000416	0.00752	CcSEcCtD
Phenylpropanolamine—Confusional state—Irinotecan—stomach cancer	0.000379	0.00685	CcSEcCtD
Phenylpropanolamine—Irritability—Methotrexate—stomach cancer	0.000364	0.00658	CcSEcCtD
Phenylpropanolamine—Confusional state—Fluorouracil—stomach cancer	0.000363	0.00656	CcSEcCtD
Phenylpropanolamine—Ataxia—Methotrexate—stomach cancer	0.000358	0.00648	CcSEcCtD
Phenylpropanolamine—Tachycardia—Fluorouracil—stomach cancer	0.000351	0.00635	CcSEcCtD
Phenylpropanolamine—Hypotension—Irinotecan—stomach cancer	0.000351	0.00635	CcSEcCtD
Phenylpropanolamine—Insomnia—Irinotecan—stomach cancer	0.00034	0.00615	CcSEcCtD
Phenylpropanolamine—Flushing—Docetaxel—stomach cancer	0.00034	0.00614	CcSEcCtD
Phenylpropanolamine—Hypotension—Fluorouracil—stomach cancer	0.000336	0.00608	CcSEcCtD
Phenylpropanolamine—Ataxia—Epirubicin—stomach cancer	0.000335	0.00606	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Irinotecan—stomach cancer	0.000335	0.00606	CcSEcCtD
Phenylpropanolamine—Somnolence—Irinotecan—stomach cancer	0.000334	0.00604	CcSEcCtD
Phenylpropanolamine—Flushing—Capecitabine—stomach cancer	0.000329	0.00594	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Docetaxel—stomach cancer	0.000327	0.00591	CcSEcCtD
Phenylpropanolamine—Insomnia—Fluorouracil—stomach cancer	0.000326	0.00589	CcSEcCtD
Phenylpropanolamine—Constipation—Irinotecan—stomach cancer	0.000322	0.00581	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Fluorouracil—stomach cancer	0.000321	0.0058	CcSEcCtD
Phenylpropanolamine—Somnolence—Fluorouracil—stomach cancer	0.00032	0.00579	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Capecitabine—stomach cancer	0.000316	0.00572	CcSEcCtD
Phenylpropanolamine—Ataxia—Doxorubicin—stomach cancer	0.00031	0.00561	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Irinotecan—stomach cancer	0.00031	0.0056	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Fluorouracil—stomach cancer	0.000297	0.00536	CcSEcCtD
Phenylpropanolamine—Drowsiness—Methotrexate—stomach cancer	0.000294	0.00531	CcSEcCtD
Phenylpropanolamine—Vision blurred—Capecitabine—stomach cancer	0.000291	0.00525	CcSEcCtD
Phenylpropanolamine—Tremor—Capecitabine—stomach cancer	0.000289	0.00522	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Irinotecan—stomach cancer	0.000277	0.00501	CcSEcCtD
Phenylpropanolamine—Drowsiness—Epirubicin—stomach cancer	0.000275	0.00497	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fluorouracil—stomach cancer	0.000265	0.0048	CcSEcCtD
Phenylpropanolamine—Confusional state—Docetaxel—stomach cancer	0.000262	0.00474	CcSEcCtD
Phenylpropanolamine—Anxiety—Capecitabine—stomach cancer	0.000262	0.00473	CcSEcCtD
Phenylpropanolamine—Drowsiness—Doxorubicin—stomach cancer	0.000254	0.0046	CcSEcCtD
Phenylpropanolamine—Confusional state—Capecitabine—stomach cancer	0.000254	0.00459	CcSEcCtD
Phenylpropanolamine—Tachycardia—Docetaxel—stomach cancer	0.000254	0.00458	CcSEcCtD
Phenylpropanolamine—Dizziness—Irinotecan—stomach cancer	0.000249	0.00449	CcSEcCtD
Phenylpropanolamine—Tachycardia—Capecitabine—stomach cancer	0.000246	0.00444	CcSEcCtD
Phenylpropanolamine—Hypotension—Docetaxel—stomach cancer	0.000243	0.00439	CcSEcCtD
Phenylpropanolamine—Vomiting—Irinotecan—stomach cancer	0.000239	0.00432	CcSEcCtD
Phenylpropanolamine—Dizziness—Fluorouracil—stomach cancer	0.000238	0.0043	CcSEcCtD
Phenylpropanolamine—Rash—Irinotecan—stomach cancer	0.000237	0.00428	CcSEcCtD
Phenylpropanolamine—Dermatitis—Irinotecan—stomach cancer	0.000237	0.00428	CcSEcCtD
Phenylpropanolamine—Hypotension—Capecitabine—stomach cancer	0.000235	0.00425	CcSEcCtD
Phenylpropanolamine—Insomnia—Docetaxel—stomach cancer	0.000235	0.00425	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Docetaxel—stomach cancer	0.000232	0.00419	CcSEcCtD
Phenylpropanolamine—Somnolence—Docetaxel—stomach cancer	0.000231	0.00418	CcSEcCtD
Phenylpropanolamine—Flushing—Epirubicin—stomach cancer	0.000229	0.00414	CcSEcCtD
Phenylpropanolamine—Vomiting—Fluorouracil—stomach cancer	0.000229	0.00414	CcSEcCtD
Phenylpropanolamine—Insomnia—Capecitabine—stomach cancer	0.000228	0.00411	CcSEcCtD
Phenylpropanolamine—Rash—Fluorouracil—stomach cancer	0.000227	0.0041	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fluorouracil—stomach cancer	0.000227	0.0041	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Capecitabine—stomach cancer	0.000224	0.00406	CcSEcCtD
Phenylpropanolamine—Nausea—Irinotecan—stomach cancer	0.000223	0.00404	CcSEcCtD
Phenylpropanolamine—Constipation—Docetaxel—stomach cancer	0.000222	0.00402	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Epirubicin—stomach cancer	0.00022	0.00398	CcSEcCtD
Phenylpropanolamine—Vision blurred—Methotrexate—stomach cancer	0.000216	0.00391	CcSEcCtD
Phenylpropanolamine—Constipation—Capecitabine—stomach cancer	0.000215	0.00389	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Docetaxel—stomach cancer	0.000214	0.00387	CcSEcCtD
Phenylpropanolamine—Nausea—Fluorouracil—stomach cancer	0.000214	0.00387	CcSEcCtD
Phenylpropanolamine—Flushing—Doxorubicin—stomach cancer	0.000212	0.00383	CcSEcCtD
Phenylpropanolamine—Tension—Epirubicin—stomach cancer	0.000211	0.00381	CcSEcCtD
Phenylpropanolamine—Nervousness—Epirubicin—stomach cancer	0.000209	0.00377	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Capecitabine—stomach cancer	0.000207	0.00375	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Doxorubicin—stomach cancer	0.000204	0.00369	CcSEcCtD
Phenylpropanolamine—Vision blurred—Epirubicin—stomach cancer	0.000202	0.00366	CcSEcCtD
Phenylpropanolamine—Agitation—Epirubicin—stomach cancer	0.000197	0.00357	CcSEcCtD
Phenylpropanolamine—Tension—Doxorubicin—stomach cancer	0.000195	0.00353	CcSEcCtD
Phenylpropanolamine—Nervousness—Doxorubicin—stomach cancer	0.000193	0.00349	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Docetaxel—stomach cancer	0.000191	0.00346	CcSEcCtD
Phenylpropanolamine—Confusional state—Methotrexate—stomach cancer	0.000189	0.00341	CcSEcCtD
Phenylpropanolamine—Vision blurred—Doxorubicin—stomach cancer	0.000187	0.00339	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Capecitabine—stomach cancer	0.000185	0.00335	CcSEcCtD
Phenylpropanolamine—Agitation—Doxorubicin—stomach cancer	0.000183	0.0033	CcSEcCtD
Phenylpropanolamine—Anxiety—Epirubicin—stomach cancer	0.000182	0.00329	CcSEcCtD
Phenylpropanolamine—Confusional state—Epirubicin—stomach cancer	0.000177	0.0032	CcSEcCtD
Phenylpropanolamine—Hypotension—Methotrexate—stomach cancer	0.000175	0.00316	CcSEcCtD
Phenylpropanolamine—Dizziness—Docetaxel—stomach cancer	0.000172	0.00311	CcSEcCtD
Phenylpropanolamine—Tachycardia—Epirubicin—stomach cancer	0.000171	0.00309	CcSEcCtD
Phenylpropanolamine—Insomnia—Methotrexate—stomach cancer	0.000169	0.00306	CcSEcCtD
Phenylpropanolamine—Anxiety—Doxorubicin—stomach cancer	0.000169	0.00305	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Methotrexate—stomach cancer	0.000167	0.00302	CcSEcCtD
Phenylpropanolamine—Somnolence—Methotrexate—stomach cancer	0.000167	0.00301	CcSEcCtD
Phenylpropanolamine—Dizziness—Capecitabine—stomach cancer	0.000166	0.00301	CcSEcCtD
Phenylpropanolamine—Vomiting—Docetaxel—stomach cancer	0.000165	0.00299	CcSEcCtD
Phenylpropanolamine—Rash—Docetaxel—stomach cancer	0.000164	0.00296	CcSEcCtD
Phenylpropanolamine—Hypotension—Epirubicin—stomach cancer	0.000164	0.00296	CcSEcCtD
Phenylpropanolamine—Dermatitis—Docetaxel—stomach cancer	0.000164	0.00296	CcSEcCtD
Phenylpropanolamine—Confusional state—Doxorubicin—stomach cancer	0.000164	0.00296	CcSEcCtD
Phenylpropanolamine—Vomiting—Capecitabine—stomach cancer	0.00016	0.00289	CcSEcCtD
Phenylpropanolamine—Rash—Capecitabine—stomach cancer	0.000159	0.00287	CcSEcCtD
Phenylpropanolamine—Insomnia—Epirubicin—stomach cancer	0.000159	0.00287	CcSEcCtD
Phenylpropanolamine—Dermatitis—Capecitabine—stomach cancer	0.000159	0.00287	CcSEcCtD
Phenylpropanolamine—Tachycardia—Doxorubicin—stomach cancer	0.000158	0.00286	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Epirubicin—stomach cancer	0.000156	0.00282	CcSEcCtD
Phenylpropanolamine—Somnolence—Epirubicin—stomach cancer	0.000156	0.00282	CcSEcCtD
Phenylpropanolamine—Nausea—Docetaxel—stomach cancer	0.000154	0.00279	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methotrexate—stomach cancer	0.000154	0.00279	CcSEcCtD
Phenylpropanolamine—Hypotension—Doxorubicin—stomach cancer	0.000152	0.00274	CcSEcCtD
Phenylpropanolamine—Constipation—Epirubicin—stomach cancer	0.00015	0.00271	CcSEcCtD
Phenylpropanolamine—Nausea—Capecitabine—stomach cancer	0.000149	0.0027	CcSEcCtD
Phenylpropanolamine—Insomnia—Doxorubicin—stomach cancer	0.000147	0.00265	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Doxorubicin—stomach cancer	0.000145	0.00261	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Epirubicin—stomach cancer	0.000144	0.00261	CcSEcCtD
Phenylpropanolamine—Somnolence—Doxorubicin—stomach cancer	0.000144	0.00261	CcSEcCtD
Phenylpropanolamine—Constipation—Doxorubicin—stomach cancer	0.000139	0.00251	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methotrexate—stomach cancer	0.000138	0.00249	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000134	0.00242	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Epirubicin—stomach cancer	0.000129	0.00233	CcSEcCtD
Phenylpropanolamine—Dizziness—Methotrexate—stomach cancer	0.000124	0.00224	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Doxorubicin—stomach cancer	0.00012	0.00216	CcSEcCtD
Phenylpropanolamine—Vomiting—Methotrexate—stomach cancer	0.000119	0.00215	CcSEcCtD
Phenylpropanolamine—Rash—Methotrexate—stomach cancer	0.000118	0.00213	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methotrexate—stomach cancer	0.000118	0.00213	CcSEcCtD
Phenylpropanolamine—Dizziness—Epirubicin—stomach cancer	0.000116	0.0021	CcSEcCtD
Phenylpropanolamine—Vomiting—Epirubicin—stomach cancer	0.000111	0.00201	CcSEcCtD
Phenylpropanolamine—Nausea—Methotrexate—stomach cancer	0.000111	0.00201	CcSEcCtD
Phenylpropanolamine—Rash—Epirubicin—stomach cancer	0.000111	0.002	CcSEcCtD
Phenylpropanolamine—Dermatitis—Epirubicin—stomach cancer	0.00011	0.002	CcSEcCtD
Phenylpropanolamine—Dizziness—Doxorubicin—stomach cancer	0.000107	0.00194	CcSEcCtD
Phenylpropanolamine—Nausea—Epirubicin—stomach cancer	0.000104	0.00188	CcSEcCtD
Phenylpropanolamine—Vomiting—Doxorubicin—stomach cancer	0.000103	0.00186	CcSEcCtD
Phenylpropanolamine—Rash—Doxorubicin—stomach cancer	0.000102	0.00185	CcSEcCtD
Phenylpropanolamine—Dermatitis—Doxorubicin—stomach cancer	0.000102	0.00185	CcSEcCtD
Phenylpropanolamine—Nausea—Doxorubicin—stomach cancer	9.64e-05	0.00174	CcSEcCtD
Phenylpropanolamine—ADRA2A—Metabolism—TYMS—stomach cancer	1.18e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.17e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CAV1—stomach cancer	1.17e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.17e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	1.17e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—APOA1—stomach cancer	1.17e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GSTM1—stomach cancer	1.16e-05	0.00015	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGFR2—stomach cancer	1.16e-05	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	1.16e-05	0.000149	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALOX5—stomach cancer	1.16e-05	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—MAPK1—stomach cancer	1.15e-05	0.000147	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—DPYD—stomach cancer	1.14e-05	0.000147	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	1.13e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	1.13e-05	0.000145	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ALB—stomach cancer	1.12e-05	0.000144	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PRKCB—stomach cancer	1.12e-05	0.000144	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6ST—stomach cancer	1.11e-05	0.000143	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	1.1e-05	0.000142	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	1.1e-05	0.000142	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ERCC2—stomach cancer	1.09e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IRS2—stomach cancer	1.09e-05	0.00014	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—KRAS—stomach cancer	1.08e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	1.08e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	1.08e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—NOS3—stomach cancer	1.07e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—APC—stomach cancer	1.07e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	1.07e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IRS2—stomach cancer	1.06e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CAV1—stomach cancer	1.05e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—APOA1—stomach cancer	1.05e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.03e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CAV1—stomach cancer	1.03e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—APOA1—stomach cancer	1.03e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MTHFR—stomach cancer	1.03e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	1.03e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FYN—stomach cancer	1.02e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—MAPK3—stomach cancer	1.02e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTT1—stomach cancer	1.01e-05	0.00013	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PRKCB—stomach cancer	1e-05	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	1e-05	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6ST—stomach cancer	9.99e-06	0.000129	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CYP2A6—stomach cancer	9.96e-06	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	9.95e-06	0.000128	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6R—stomach cancer	9.92e-06	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	9.91e-06	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PRKCB—stomach cancer	9.82e-06	0.000126	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—stomach cancer	9.81e-06	0.000126	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6ST—stomach cancer	9.78e-06	0.000126	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—MAPK1—stomach cancer	9.73e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—EGFR—stomach cancer	9.73e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AKR1C3—stomach cancer	9.69e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	9.69e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TP53—stomach cancer	9.62e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	9.61e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—APC—stomach cancer	9.6e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FYN—stomach cancer	9.51e-06	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CAV1—stomach cancer	9.48e-06	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—APOA1—stomach cancer	9.46e-06	0.000122	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ENO1—stomach cancer	9.44e-06	0.000121	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—APC—stomach cancer	9.39e-06	0.000121	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—PIK3CA—stomach cancer	9.3e-06	0.00012	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SERPINE1—stomach cancer	9.29e-06	0.000119	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.29e-06	0.000119	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—HRAS—stomach cancer	9.2e-06	0.000118	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	9.2e-06	0.000118	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—KRAS—stomach cancer	9.19e-06	0.000118	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	9e-06	0.000116	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	9e-06	0.000116	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RHOA—stomach cancer	8.96e-06	0.000115	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	8.93e-06	0.000115	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6R—stomach cancer	8.92e-06	0.000115	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOS3—stomach cancer	8.87e-06	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IRS2—stomach cancer	8.8e-06	0.000113	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	8.75e-06	0.000113	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—EGFR—stomach cancer	8.75e-06	0.000113	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6R—stomach cancer	8.72e-06	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	8.56e-06	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—EGFR—stomach cancer	8.56e-06	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CAV1—stomach cancer	8.53e-06	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—APOA1—stomach cancer	8.51e-06	0.000109	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—PIK3CA—stomach cancer	8.45e-06	0.000109	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CD44—stomach cancer	8.37e-06	0.000108	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	8.36e-06	0.000108	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	8.35e-06	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARG—stomach cancer	8.33e-06	0.000107	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ERBB2—stomach cancer	8.29e-06	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—KRAS—stomach cancer	8.27e-06	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	8.18e-06	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	8.17e-06	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	8.17e-06	0.000105	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.13e-06	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	8.12e-06	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	8.09e-06	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—KRAS—stomach cancer	8.09e-06	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RHOA—stomach cancer	8.06e-06	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOS3—stomach cancer	7.97e-06	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	7.93e-06	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	7.91e-06	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RHOA—stomach cancer	7.88e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—stomach cancer	7.87e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HRAS—stomach cancer	7.81e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOS3—stomach cancer	7.8e-06	0.0001	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—APC—stomach cancer	7.77e-06	0.0001	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CDKN1B—stomach cancer	7.68e-06	9.88e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	7.59e-06	9.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	7.54e-06	9.7e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	7.51e-06	9.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—stomach cancer	7.49e-06	9.64e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—stomach cancer	7.48e-06	9.62e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ERBB2—stomach cancer	7.46e-06	9.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	7.44e-06	9.57e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	7.43e-06	9.56e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCND1—stomach cancer	7.33e-06	9.43e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—JUN—stomach cancer	7.31e-06	9.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ERBB2—stomach cancer	7.29e-06	9.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—APC—stomach cancer	7.22e-06	9.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6R—stomach cancer	7.22e-06	9.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NOS3—stomach cancer	7.17e-06	9.22e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	7.12e-06	9.16e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—stomach cancer	7.11e-06	9.15e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CDKN1A—stomach cancer	7.09e-06	9.12e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	7.08e-06	9.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	7.08e-06	9.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—stomach cancer	7.07e-06	9.1e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HRAS—stomach cancer	7.03e-06	9.04e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTP1—stomach cancer	6.99e-06	8.99e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK8—stomach cancer	6.92e-06	8.9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—stomach cancer	6.92e-06	8.9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	6.91e-06	8.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	6.91e-06	8.88e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—HMOX1—stomach cancer	6.89e-06	8.86e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HRAS—stomach cancer	6.87e-06	8.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	6.77e-06	8.7e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	6.76e-06	8.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	6.76e-06	8.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—stomach cancer	6.72e-06	8.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	6.7e-06	8.62e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	6.69e-06	8.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCND1—stomach cancer	6.59e-06	8.47e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	6.58e-06	8.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—stomach cancer	6.58e-06	8.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	6.58e-06	8.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—JUN—stomach cancer	6.57e-06	8.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—stomach cancer	6.56e-06	8.43e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	6.52e-06	8.38e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—TYMS—stomach cancer	6.49e-06	8.35e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	6.45e-06	8.3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCND1—stomach cancer	6.44e-06	8.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—JUN—stomach cancer	6.43e-06	8.27e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTM1—stomach cancer	6.42e-06	8.26e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—stomach cancer	6.4e-06	8.23e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VEGFA—stomach cancer	6.39e-06	8.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	6.37e-06	8.2e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—STAT3—stomach cancer	6.33e-06	8.14e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	6.29e-06	8.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	6.28e-06	8.07e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—stomach cancer	6.26e-06	8.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	6.23e-06	8.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK8—stomach cancer	6.22e-06	8e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	6.21e-06	7.99e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	6.14e-06	7.9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK8—stomach cancer	6.08e-06	7.83e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	6.06e-06	7.79e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK3—stomach cancer	6.04e-06	7.77e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PIK3CA—stomach cancer	6.04e-06	7.77e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ERCC2—stomach cancer	6.04e-06	7.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	6.03e-06	7.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	5.99e-06	7.71e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MYC—stomach cancer	5.88e-06	7.56e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK1—stomach cancer	5.75e-06	7.4e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EGFR—stomach cancer	5.75e-06	7.4e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VEGFA—stomach cancer	5.74e-06	7.39e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	5.72e-06	7.36e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	5.71e-06	7.34e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—STAT3—stomach cancer	5.69e-06	7.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	5.68e-06	7.31e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—stomach cancer	5.67e-06	7.3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VEGFA—stomach cancer	5.62e-06	7.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	5.61e-06	7.21e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	5.59e-06	7.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—STAT3—stomach cancer	5.56e-06	7.16e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	5.44e-06	7e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK3—stomach cancer	5.43e-06	6.99e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—KRAS—stomach cancer	5.43e-06	6.99e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	5.33e-06	6.86e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—JUN—stomach cancer	5.32e-06	6.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	5.32e-06	6.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK3—stomach cancer	5.31e-06	6.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MYC—stomach cancer	5.28e-06	6.8e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	5.28e-06	6.79e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAV1—stomach cancer	5.23e-06	6.73e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APOA1—stomach cancer	5.22e-06	6.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	5.19e-06	6.68e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	5.18e-06	6.66e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK1—stomach cancer	5.17e-06	6.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MYC—stomach cancer	5.17e-06	6.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EGFR—stomach cancer	5.17e-06	6.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	5.16e-06	6.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK1—stomach cancer	5.06e-06	6.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EGFR—stomach cancer	5.06e-06	6.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	5.06e-06	6.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	5.03e-06	6.47e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5e-06	6.43e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	4.99e-06	6.42e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	4.95e-06	6.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—JUN—stomach cancer	4.94e-06	6.36e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—KRAS—stomach cancer	4.88e-06	6.28e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TP53—stomach cancer	4.83e-06	6.21e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	4.81e-06	6.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	4.79e-06	6.16e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—KRAS—stomach cancer	4.78e-06	6.14e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	4.68e-06	6.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	4.65e-06	5.98e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HRAS—stomach cancer	4.62e-06	5.94e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	4.6e-06	5.92e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARG—stomach cancer	4.6e-06	5.92e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	4.49e-06	5.77e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—stomach cancer	4.42e-06	5.68e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	4.4e-06	5.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	4.39e-06	5.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TP53—stomach cancer	4.34e-06	5.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	4.32e-06	5.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MYC—stomach cancer	4.28e-06	5.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	4.28e-06	5.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TP53—stomach cancer	4.25e-06	5.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	4.18e-06	5.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	4.18e-06	5.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HRAS—stomach cancer	4.15e-06	5.34e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—stomach cancer	4.14e-06	5.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	4.08e-06	5.25e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HRAS—stomach cancer	4.06e-06	5.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PIK3CA—stomach cancer	4.03e-06	5.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MYC—stomach cancer	3.97e-06	5.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—stomach cancer	3.97e-06	5.11e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NOS3—stomach cancer	3.96e-06	5.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	3.95e-06	5.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	3.89e-06	5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—stomach cancer	3.89e-06	5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	3.89e-06	5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	3.67e-06	4.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	3.63e-06	4.67e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—stomach cancer	3.62e-06	4.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TP53—stomach cancer	3.51e-06	4.52e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	3.37e-06	4.34e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	3.36e-06	4.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TP53—stomach cancer	3.26e-06	4.2e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—stomach cancer	3.21e-06	4.13e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	3.12e-06	4.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.99e-06	3.84e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.23e-06	2.86e-05	CbGpPWpGaD
